Evidence map›Paper›PMID 26373870›Full record

ArticleEnvironmental microbiology2015

Dynamic exometabolome analysis reveals active metabolic pathways in non-replicating mycobacteria.

Michael Zimmermann, Andreas Kuehne, Helena I Boshoff, Clifton E Barry, Nicola Zamboni, Uwe Sauer

Open access · greenAbstract read
In one paragraph

Article in Environmental microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Understanding the contribution of metabolism toFrontiers in cellular and infection microbiology · 2022
    Review
  4. Article
  5. Review
  6. Metabolic Versatility ofMetabolites · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. One-Year Old Dormant, "Non-culturable"Frontiers in cellular and infection microbiology · 2020
    Article
  11. Article
  12. Chemical disarming of isoniazid resistance inProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Protein Composition ofFrontiers in microbiology · 2018
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Michael ZimmermannInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Andreas KuehneInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Helena I BoshoffTuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Clifton E BarryTuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Nicola ZamboniInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Uwe SauerInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
ETH Zurich · CHNational Institutes of Health · USLife Science Zurich · CH

Funding

Exploring the metabolism of non-replicating and drug-resistant TBZIAAI000783 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2009 to 2017
$8.2M
Intramural NIH HHS ZIA AI000783
6 · The paper itself

Abstract

An organism's metabolic activity leaves an extracellular footprint and dynamic changes in this exometabolome inform about nutrient uptake, waste disposal and signalling activities. Using non-targeted mass spectrometry, we report exometabolome dynamics of hypoxia-induced, non-replicating mycobacteria that are thought to play a role in latent tuberculosis. Despite evidence of active metabolism, little is known about the mechanisms enabling obligate aerobic mycobacteria to cope with hypoxia, resulting in long-term survival and increased chemotherapeutic tolerance. The dynamics of 379 extracellular compounds of Mycobacterium smegmatis were deconvoluted with a genome-scale metabolic reaction-pair network to generate hypotheses about intracellular pathway usage. Time-resolved (13) C-tracing and mutant experiments then demonstrated a crucial, energy-generating role of asparagine utilization and non-generic usage of the glyoxylate shunt for hypoxic fitness. Experiments with M. bovis and M. tuberculosis revealed the general relevance of asparagine fermentation and a variable contribution of the glyoxylate shunt to non-replicative, hypoxic survival between the three species.

Indexed as

AsparagineFermentationGlyoxylatesMetabolic Networks and PathwaysMetabolomeMycobacterium smegmatisMycobacterium tuberculosisOxygenAsparagineGlyoxylatesOxygen

Identifiers

PMID26373870
PMCPMC10500702
OpenAlexW1941606048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.